Literature DB >> 21186135

Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability.

Kimberly Papay1, Eugenia Mamikonyan, Andrew D Siderowf, John E Duda, Kelly E Lyons, Rajesh Pahwa, Erika D Driver-Dunckley, Charles H Adler, Daniel Weintraub.   

Abstract

Questions exist regarding the validity of patient-reporting of psychiatric symptoms in Parkinson's disease (PD). We assessed observer variability and validity in reporting of impulse control disorder (ICD) symptoms in PD by using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP). PD patients and their informants (71 pairs) completed the QUIP to assess four ICDs (compulsive gambling, buying, sexual behavior, and eating) in patients. Trained raters then administered a diagnostic interview. Sensitivity of the QUIP for a diagnosed ICD was 100% for both patient- and informant-completed instruments, and specificity was 75% for both raters. Approximately 40% of patients without an ICD diagnosis had a positive QUIP, suggesting that many PD patients experience subsyndromal ICD symptoms that require ongoing monitoring. Agreement between patient- and informant-reporting of any ICD behaviors on the QUIP was moderate (kappa=0.408), and for individual ICDs was highest for gambling (kappa=0.550). Overall, a negative QUIP from either the patient or informant rules out the possibility of an ICD, while a positive QUIP requires a follow-up diagnostic interview and ongoing monitoring to determine if symptoms currently are, or in the future become, clinically significant.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21186135      PMCID: PMC3073062          DOI: 10.1016/j.parkreldis.2010.11.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

1.  Preliminary validity and reliability testing of a structured clinical interview for pathological gambling.

Authors:  Jon E Grant; Marvin A Steinberg; Suck Won Kim; Bruce J Rounsaville; Marc N Potenza
Journal:  Psychiatry Res       Date:  2004-08-30       Impact factor: 3.222

2.  Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic).

Authors:  Thomas McGinn; Peter C Wyer; Thomas B Newman; Sheri Keitz; Rosanne Leipzig; Gordon Guyatt For
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

Review 3.  Medication-related impulse control and repetitive behaviors in Parkinson disease.

Authors:  Valerie Voon; Susan H Fox
Journal:  Arch Neurol       Date:  2007-08

4.  Pathological gambling caused by drugs used to treat Parkinson disease.

Authors:  M Leann Dodd; Kevin J Klos; James H Bower; Yonas E Geda; Keith A Josephs; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2005-07-11

5.  Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Authors:  Daniel Weintraub; Andrew D Siderowf; Marc N Potenza; Joseph Goveas; Knashawn H Morales; John E Duda; Paul J Moberg; Matthew B Stern
Journal:  Arch Neurol       Date:  2006-07

6.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

Authors:  L M Shulman; R L Taback; A A Rabinstein; W J Weiner
Journal:  Parkinsonism Relat Disord       Date:  2002-01       Impact factor: 4.891

7.  Psychiatric patient and informant reports of patient behavior.

Authors:  Rebecca E Ready; Lee Anna Clark
Journal:  J Pers       Date:  2005-02

8.  Study of compulsive buying in depressed patients.

Authors:  M Lejoyeux; V Tassain; J Solomon; J Adès
Journal:  J Clin Psychiatry       Date:  1997-04       Impact factor: 4.384

9.  Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.

Authors:  V Voon; K Hassan; M Zurowski; M de Souza; T Thomsen; S Fox; A E Lang; J Miyasaki
Journal:  Neurology       Date:  2006-09-06       Impact factor: 9.910

10.  Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.

Authors:  G Giovannoni; J D O'Sullivan; K Turner; A J Manson; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

View more
  27 in total

1.  Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

Authors:  Daniel Weintraub; Eugenia Mamikonyan; Kimberly Papay; Judith A Shea; Sharon X Xie; Andrew Siderowf
Journal:  Mov Disord       Date:  2011-12-01       Impact factor: 10.338

Review 2.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

3.  Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease.

Authors:  Jason Brandt; Mark Rogerson; Haya Al-Joudi; Gila Reckess; Barnett Shpritz; Chizoba C Umeh; Noha Aljehani; Kelly Mills; Zoltan Mari
Journal:  Neuropsychology       Date:  2014-12-08       Impact factor: 3.295

4.  Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Authors:  Atbin Djamshidian; Sean S O'Sullivan; Yanosh Sanotsky; Stephen Sharman; Yuriy Matviyenko; Thomas Foltynie; Rosanna Michalczuk; Iciar Aviles-Olmos; Ludmyla Fedoryshyn; Karen M Doherty; Yuriy Filts; Marianna Selikhova; Henrietta Bowden-Jones; Eileen Joyce; Andrew J Lees; Bruno B Averbeck
Journal:  Mov Disord       Date:  2012-07-20       Impact factor: 10.338

5.  Impulsive compulsive behaviours in Parkinson's disease: patients' versus caregivers' perceptions.

Authors:  L Ricciardi; B Demartini; M Pomponi; D Ricciardi; B Morabito; R Renna; R Bernabei; A R Bentivoglio
Journal:  J Neurol       Date:  2016-03-10       Impact factor: 4.849

Review 6.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  Anna Nagy; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-29       Impact factor: 3.575

7.  The addiction-related gene ANKK1 in Parkinsonian patients with impulse control disorder.

Authors:  Janet Hoenicka; Pedro J García-Ruiz; Guillermo Ponce; Antonio Herranz; Dolores Martínez-Rubio; Estela Pérez-Santamarina; Francesc Palau
Journal:  Neurotox Res       Date:  2014-12-02       Impact factor: 3.911

Review 8.  Impulse control disorders in Parkinson's disease: recent advances.

Authors:  Valerie Voon; Arpan R Mehta; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

9.  Impulse control disorders in Parkinson's disease: background and update on prevention and management.

Authors:  Robert F Leeman; Benjamin E Billingsley; Marc N Potenza
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

Review 10.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.